6,6'-取代1,1'-联二萘酚衍生的手性磷酸的合成

1,1'-联二萘酚(1)经溴代反应制得6,6'-二溴-1,1'-联二萘酚(2);2经苄基保护羟基制得2,2'-二苄氧基-6,6'-二溴-1,1'-联二萘(3);3经Ullmann缩合在6,6'-位引入甲氧基制得2,2'-二苄氧基-6,6'-二甲氧基-1,1'-联二萘(4b);3经Kumada偶联反应在6,6'-位引入正己基制得2,2'-二苄氧基-6,6'-二正己基-1,1'-联二萘(4c);4b和4c经还原脱去苄基制得6,6'-位取代1,1'-联二萘酚(5b和5c);2,5b和5c分别与三氯氧磷反应合成了3种1的6,6'-位取代手性磷酸(6a~6c),其结构经1H NMR和31P NMR表征。其中6c为新化合物。     

钝化萘衍生物的磺化反应研究

研究了带吸电子取代基的一系列钝化萘衍生物与SO~3进行的磺化反应, 用^1H NMR分析反应混合物的组成.1-萘磺酸以71:20:9的比例产生1,5-, 1,6-和1,7-萘二磺酸, 进一步磺化得到1,3,5-, 1,3,6-萘三磺酸和1,3,5,7-萘四磺酸. 1-萘甲醛的单硫化得到比例为55:9:6:30的5-, 6-,7-和8-磺酸取代物. 1-苯甲酮萘则以83:11:6的比例得到5-,6-,和7-磺酸取代物. 1-硝基萘仅得到5位磺化产物. 1-萘甲酸和1-萘甲酸甲酯得到5位和8位取代产物. 所有的2位取代萘衍生物均先得到5和8位取代产物. 提出了生成SO~3络合物及迫位磺化的历程.     

带有致钝取代基的萘衍生物和SO3的反应研究

研究了一系列带有醛基、苯甲酮基、羧基、酯基和硝基等致钝取代基的萘衍生物与SO₃的反应。1-萘甲醛的单磺化得到比例为55:9:6:30的5-、6-、7-和8-磺酸取代物。1-苯甲酮萘则以83:11:6的比例得到5-、6-和7-磺酸取代物。1-硝基萘专一地得到5位磺化产物,1-萘甲酸和1-萘甲酸甲酯得到5位和8位取代产物。所有的2位取代萘衍生物均先得到5和8位取代产物,在过量磺化中生成的主产物为5,7-二磺酸取代物,提出了生成SO₃络合物及迫位磺化的历程,报道了8-磺酸-1-萘甲酸酐的物理数据。     

天然产物Combretastatin A-1和Combretastatin B-1的合成

基于Perkin反应策略合成了具有强效抗肿瘤、抗血管活性的天然产物Combretastatin A-1(CA1)和Combretastatin B-1(CB1).以2,3,4-三羟基苯甲醛(1)为起始物, 经单甲基化反应得到2,3-二羟基-4-甲氧基苯甲醛(2), 再经酚羟基保护得到2,3-二异丙基-4-甲氧基苯甲醛(3), 该化合物与3,4,5-三甲氧基苯乙酸(4)发生Perkin反应分离得到E-2-(3,4,5-三甲氧基苯基)-3-(2',3'-二异丙氧基-4'-甲氧基)丙烯酸(E-5), 经脱羧反应得到Z-3,4,4',5-四甲氧基-2',3'-二异丙氧基二苯乙烯(6), 最后经脱保护反应得到CA1.另外, 将E-2-(3,4,5-三甲氧基苯基)-3-(2',3'-二异丙氧基-4'-甲氧基)丙烯酸(E-5)脱去保护基得到E-2-(3,4,5-三甲氧基苯基)-3-(2',3'-二羟基-4'-甲氧基)丙烯酸(7), 该化合物经脱羧-异构化反应得到E-3,4,4',5-四甲氧基-2',3'-二羟基二苯乙烯(E-CA1), 最后经催化氢化得到CB1.     

新型P,N配体及基1,4-共轭加成反应

以2-萘酚为起始原料,经过氧化偶联,消旋体的拆分得到手性骨架2-氨基-2'-羟基-1,1'-联萘(NOBIN),并以S-NOBIN为原料,经过六步反应合成了两个新型配体S-(+)-2-(2-吡啶酰胺基)-2'-二苯基膦基-1,1'-联萘(1a)和S-(+)-2-(6-甲基-2-吡啶酰胺基)-2'-二苯基膦基-1,1'-联萘(1b)。并进行了铜配合物催化的二乙基锌对2-环己烯酮的1,4-共轭加成反应的研究。反应产物3-乙基环己酮(13)的e.e.值高达92%。     

新型P,N配体及基1,4-共轭加成反应

以2-萘酚为起始原料,经过氧化偶联,消旋体的拆分得到手性骨架2-氨基-2'-羟基-1,1'-联萘(NOBIN),并以S-NOBIN为原料,经过六步反应合成了两个新型配体S-(+)-2-(2-吡啶酰胺基)-2'-二苯基膦基-1,1'-联萘(1a)和S-(+)-2-(6-甲基-2-吡啶酰胺基)-2'-二苯基膦基-1,1'-联萘(1b)。并进行了铜配合物催化的二乙基锌对2-环己烯酮的1,4-共轭加成反应的研究。反应产物3-乙基环己酮(13)的e.e.值高达92%。     

海洋真菌赤褐炭团菌FS521的次级代谢产物研究（英文）

从海洋真菌赤褐炭团菌(Hypoxylon rubiginosum) FS521中分离纯化得到17个聚酮类化合物,分别鉴定为4-乙酰氧基-8-甲氧基-3,4-二氢萘-1(2H)-酮(1)、4,8-二甲氧基-1-萘酚(2)、1'-羟基-4',8,8'-三甲氧基[2,2']联萘-1,4-二酮(3)、3,6-dimethyl-atromentin (4)、4-羟基-8-甲氧基-3,4-二氢萘-1(2H)-酮(5)、regiolone (6)、methylsclerone (7)、5-methylmellein(8)、3,5-二甲基-8-甲氧基-3,4-二羟基异香豆素(9)、9-甲氧基萘(10)、1,8-二甲氧基萘(11)、8-甲氧基-1-萘醇(12)、7-甲氧基-3-甲基异苯并呋喃(13)、3-甲基-4-羟基苯乙酸(14)、nodulisporipyrone A (15)、nodulisporipyrone B (16)、3,4-二甲氧基-乙酰苯乙醇(17).其中化合物1为新化合物,化合物2和3为新天然产物,新化合物的结构通过HRESIMS, 1D NMR和2DNMR等光谱技术确定.此外,对分离所得的化合物1～4进行了体外细胞毒活性测试,结果表明化合物3对SF-268、MCF-7、Hep G-2、A549有较强的细胞毒活性,其IC_(50)值分别为1.85、3.21、2.53、5.09mmol·L~(-1).     

聚[(S)-3-乙烯基-2,2'-二羟基-1,1'-联萘]的钛配合物催化三乙基铝对醛的不对称加成反应

通过维蒂希反应合成了(S)-3-乙烯基-2,2'-甲氧甲氧基-1,1'-联萘.将单体(S)-3-乙烯基-2,2'-甲氧甲氧基-1,1'-联萘用偶氮二异丁腈作引发剂进行自由基聚合得到了聚[(S)-3-乙烯基-2,2'-二甲氧基甲氧基-1,1'-联萘].该聚合物上的MOM保护基通过酸脱除获得手性螺旋聚合物聚[(S)-3-乙烯基-2,2'-二羟基-1,1'-联萘].将手性螺旋聚合物聚[(S)-3-乙烯基-2,2'-二羟基-1,1'-联萘]与Ti(O-i-Pr)4形成的配合物应用于三乙基铝与醛的不对称加成反应中,获得了较好的对映选择性,ee值最高为85%.更重要的是,这种聚合物还可以被回收利用多次且催化活性没有明显降低.     

(S)-6-丙烯酰基-2-甲氧基-2’-特戊酰氧基-1,1’-联萘负离子聚合合成螺旋聚α,β-不饱和酮

在三氯化铝作用下(S)-2-甲氧基-2’-特戊酰氧基-1,1’-联萘经酰基化反应生成(S)-6-(3-氯丙酰基)-2-甲氧基-2’-特戊酰氧基-1,1’-联萘2a.在三乙胺存在条件下2a脱去氯化氢生成了(S)-6-丙烯酰基-2-甲氧基-2’-特戊酰氧基-1,1’-联萘3.将单体3用正丁基锂作引发剂在甲苯溶液中进行了负离子聚合.聚合物3的比旋光度的绝对值[α]25589为+96,是其单体3的8倍.通过对照聚合物和单体以及模型化合物如(S)-6-丙酰基-2-甲氧基-2’-特戊酰氧基-1,1’-联萘2b和(S)-6-庚酰基-2-甲氧基-2’-特戊酰氧基-1,1’-联萘2c之间的比旋光度和圆二色谱,确认聚合物3以单手性螺旋结构的形式存在于溶液中.聚合物3的各向异性因子g值是其单体的18倍,这也证实了聚合物3的单手性螺旋结构.     

磺化侧苯基杂萘联苯聚醚酮酮的合成与性能

以4-(3-苯基-4-羟基苯基)-2,3-二氮杂萘-1-酮(DHPZ-P)、 4-(4-羟基苯基)-2,3-二氮杂萘-1-酮(DHPZ)和1,4-二(4'-氟苯甲酰基)苯(BFBB)为原料, 经溶液亲核取代缩聚反应, 通过调节DHPZ-P和DHPZ的比例, 合成了一系列侧苯基杂萘联苯聚醚酮酮(PPEKK-P), 然后以浓硫酸为磺化剂, 制备出一系列磺化侧苯基杂萘联苯聚醚酮酮(SPPEKK-P). 利用傅里叶变换红外光谱(FTIR)和氢核磁共振谱(¹H NMR)对聚合物结构进行表征, 结果表明, 磺酸基团引入到聚合物链的侧苯基上. 采用溶液浇铸法制备SPPEKK-P质子交换膜. SPPEKK-P膜的吸水率、 溶胀率和质子传导率均随离子交换容量(IEC)的增加而增加, 且具有较好的耐氧化性. IEC最高的SPPEKK-P-100膜的质子传导率在95℃能达到7.44×10^-2 S/cm, 且甲醇渗透系数为5.57×10^-8 cm²/s, 阻醇性能优于Nafion117膜.     

Zur Synthese sulfonierter Derivate von 4-Amino-1,3-dimethylbenzol und 2-Amino-1,3-dimethylbenzol

Syntheses of Sulfonated Derivatives of 4-Amino-1, 3-dimethylbenzene and 2-Amino-1, 3-dimethylbenzene Direct sulfonation of 4-amino-1, 3-dimethylbenzene (1) and sulfonation of 4-nitro-1,3-dimethylbenzene ( 4 ) to 4-nitro-1,3-dimethylbenzene-6-sulfonic acid ( 3 ) followed by reduction yield 4-amino-1,3-dimethylbenzene-6-sulfonic acid ( 2 ). The isomeric 5-sulfonic acid ( 5 ) however is prepared solely by baking the acid sulfate salt of 1 . Reaction of sulfur dioxide with the diazonium chloride derived from 2-amino-4-nitro-1,3-dimethylbenzene ( 7 ) leads to 4-nitro-1,3-dimethylbenzene-2-sulfonyl chloride ( 8 ), which is successively hydrolyzed to 4-nitro-1,3-dimethylbenzene-2-sulfonic acid ( 9 ) and reduced to 4-amino-1, 3-dimethylbenzene-2-sulfonic acid ( 6 ). Treatment of 4-amino-6-bromo-1,3-dimethylbenzene ( 12 ) and 4-amino-6-chloro-1, 3-dimethylbenzene ( 13 ), the former obtained by reduction of 4-chloro-6-nitro-1,3-dimethyl-benzene ( 10 ) and the latter from 4-chloro-6-nitro-1, 3-dimethylbenzene ( 11 ), with oleum yield 4-amino-6-bromo-1,3-dimethylbenzene-2-sulfonic acid ( 14 ) and 4-amino-6-chloro-1,3-dimethylbenzene-2-sulfonic acid ( 15 ) respectively; subsequent carbon-halogen hydrogenolyses of 14 and 15 lead also to 6 (Scheme 1). Baking the acid sulfate salt of 2-amino-1, 3-dimethylbenzene ( 17 ) gives 2-amino-1, 3-dimethylbenzene-5-sulfonic acid ( 16 ), whereas the isomeric 4-sulfonic acid ( 18 ) can be prepared by either of the following three possible pathways: Sulfonation of 2-nitro-1,3-dimethylbenzene ( 20 ) to 2-nitro-1,3-dimethylbenzene-4-sulfonic acid ( 21 ) followed by reduction or sulfonation of 2-acetylamino-1,3-dimethylbenzene ( 19 ) to 2-acetylamino-1,3-dimethylbenzene-4-sulfonic acid ( 22 ) with subsequent hydrolysis or direct sulfonation of 17 . Further sulfonation of 18 yields 2-amino 1,3-dimethylbenzene-4,6-disulfonic acid ( 23 ), the structure of which is independently confirmed by reduction of unequivocally prepared 2-nitro- 1,:3-dimethylbenzene-4,6-disulfonic acid ( 24 )(Scheme 2).     

Zur Synthese sulfonierter Derivate von 4- und 5-Aminoindan

On the Synthesis of Sulfonated Derivatives of 4- and 5-Aminoindan Baking the hydrogensulfate salt of 4-aminoindan (1) and 5-aminoindan (2) led, respectively, to 4-aminoindan-7-sulfonic acid (3) and 5-aminoindan-6-sulfonic acid (4). Acid 4 was also obtained by direct sulfonation of 2. 4-Aminoindan-6-sulfonic acid (5) and 6-aminoindan-4-sulfonic acid (6) were prepared by sulfonation of 4-nitroindan (7) and 5-nitroindan (9) , respectively, to 4-nitroindan-6-sulfonic acid (8) and 6-nitroindan-4-sulfonic acid (10) , followed by a Béchamp-reduction. Treatment of 1 with amidosulfuric acid gave 3 , whereas the same reaction with 2 led to a mixture of 4 and 5-aminoindan-4-sulfonic acid (11). Independent synthesis of 11 was achieved by the following sequence of reactions: sulfur dioxide treatment of the diazonium chloride derived from 4-amino-5-nitrodan (13) gave 5-nitroindan-4-sulfonyl chloride (14) ; hydrolysis to 5-nitroindan-4-sulfonic acid (15) , and final reduction. The 4-aminoindan-5-sulfonic acid (16) was synthesized by treatment of 4-amino-7-bromoindan (18) with amidosulfuric acid to give 4-amino-7-bromoindan-5-sulfonic acid (19) followed by hydrogenolysis. Sulfonation of 4-acetyl-amino-7-bromoindan (17) with oleum followed by hydrolysis led to 7-amino-4-bromoindan-5-sulfonic acid (20) , the structure of which was confirmed by reductive dehalogenation to 5 .     

Synthesis and catalytic activity of group 5 metal amides with chiral biaryldiamine-based ligands

A new series of group 5 metal amides have been prepared from the reaction between V(NMe(2))(4) or M(NMe(2))(5) (M = Nb, Ta) and chiral ligands, (R)-2,2'-bis(mesitoylamino)-1,1'-binaphthyl (1H(2)), (R)-5,5',6,6',7,7',8,8'-octahydro-2,2'-bis(mesitoylamino)-1,1'-binaphthyl (2H(2)), (R)-6,6'-dimethyl-2,2'-bis(mesitoylamino)-1,1'-biphenyl (3H(2)), (R)-2,2'-bis(mesitylenesulfonylamino)-6,6'-dimethyl-1,1'-biphenyl (4H(2)), (R)-2,2'-bis(diphenylthiophosphoramino)-1,1'-binaphthyl (5H(2)), (R)-2,2'-bis[(3-tert-butyl-2-hydroxybenzylidene)amino]-6,6'-dimethyl-1,1'-biphenyl (6H(2)), (R)-2,2'-bis[(3,5-di-tert-butyl-2-hydroxybenzylidene)amino]-6,6'-dimethyl-1,1'-biphenyl (7H(2)), (R)-2,2'-bis[(3-tert-butyl-2-hydroxybenzylidene)amino]-1,1'-binaphthyl (8H(2)), (S)-2-(mesitoylamino)-2'-(dimethylamino)-1,1'-binaphthyl (9H), and (R)-2-(mesitoylamino)-2'-(dimethylamino)-6,6'-dimethyl-1,1'-biphenyl (10H), which are derived from (R) or (S)-2,2'-diamino-1,1'-binaphthyl, and (R)-2,2'-diamino-6,6'-dimethyl-1,1'-biphenyl, respectively. Treatment of V(NMe(2))(4) or M(NMe(2))(5) (M = Nb, Ta) with 1 equiv of C(2)-symmetric amidate ligands 1H(2), 2H(2), 3H(2), 4H(2), and 5H(2), or Schiff base ligands 6H(2), 7H(2) and 8H(2) at room temperature gives, after recrystallization from a benzene, toluene or n-hexane solution, the vanadium amides (1)V(NMe(2))(2) (11), (2)V(NMe(2))(2) (14), (3)V(NMe(2))(2) (17), (5)V(NMe(2))(2) (22), (6)V(NMe(2))(2) (23) and (7)V(NMe(2))(2) (24), and niobium amides (1)Nb(NMe(2))(3) (12), (2)Nb(NMe(2))(3) (15), (3)Nb(NMe(2))(3) (18), (4)Nb(NMe(2))(3) (20) and [2-(3-Me(3)C-2-O-C(6)H(3)CHN)-2'-(N)-C(20)H(12)][2-(Me(2)N)(2)CH-6-CMe(3)-C(6)H(3)O]NbNMe(2)·C(7)H(8) (25·C(7)H(8)), and tantalum amides (1)Ta(NMe(2))(3) (13), (2)Ta(NMe(2))(3) (16), (3)Ta(NMe(2))(3) (19) and (4)Ta(NMe(2))(3) (21) respectively, in good yields. Reaction of V(NMe(2))(4) or M(NMe(2))(5) (M = Nb, Ta) with 2 equiv of C(1)-symmetric amidate ligands 9H or 10H at room temperature gives, after recrystallization from a toluene or n-hexane solution, the chiral bis-ligated vanadium amides (9)(2)V(NMe(2))(2)·3C(7)H(8) (27·3C(7)H(8)) and (10)V(NMe(2))(2) (28), and chiral bis-ligated metallaaziridine complexes (10)(2)M(NMe(2))(η(2)-CH(2)NMe) (M = Nb (29), Ta (30)) respectively, in good yields. The niobium and tantalum amidate complexes are stable in a toluene solution at or below 160 °C, while the vanadium amidate complexes degrade via diemthylamino group elimination at this temperature. For example, heating the complex (2)V(NMe(2))(2) (14) in toluene at 160 °C for four days leads to the isolation of the complex [(2)V](2)(μ-NMe(2))(2) (26) in 58% yield. These new complexes have been characterized by various spectroscopic techniques, and elemental analyses. The solid-state structures of complexes 12, 13, and 15-30 have further been confirmed by X-ray diffraction analyses. The vanadium amides are active chiral catalysts for the asymmetric hydroamination/cyclization of aminoalkenes, affording cyclic amines in moderate to good yields with good ee values (up to 80%), and the tantalum amides are outstanding chiral catalysts for the hydroaminoalkylation, giving chiral secondary amines in good yields with excellent ee values (up to 93%).     

Chiral hybrid metal-organic dendrimers

[structure: see text] New chiral terpyridines containing Frechét-type dendrons have been readily synthesized by coupling dendritic benzyl bromide and 4'-[6-(2,2'-dihydroxy-1,1'-binaphthyl)]-2,2':6'2' '-terpyridine. These chiral dendritic terpyridines were used to efficiently construct high molecular weight hybrid metal-organic dendrimers based on the Ru(II)-bis(terpy) linkage. Preliminary fluorescence measurements show generation-dependent fluorescence quenching behavior of 3,5-dimethoxybenzyl peripherals by the [Ru(terpy)(2)](2+) unit.     

铜(Ⅰ)配合物的不对称催化1,4-共轭加成反应

以两个新型手性配体S-(+)-2-(2-吡啶酰胺基)-2'-(二苯基膦基)-1,1'-联苯(1a)和S-(+)-2-(6-甲基-2-吡啶酰胺基)-2'-(二苯基膦基)-1,1'-联萘(1b)的铜配合物催化的二乙基锌对开链烯酮的1,4-共轭加成反应的研究。以1a为标准配体,查耳酮为代表性底物,考察了溶剂、催化剂前体等因素对反应的影响。在优化条件下,系统研究了以[Cu(OTf)](C~6H~6)~1~/~2/1b为催化剂,甲苯-二氯乙烷为溶剂时进行了二乙基锌对七个开链烯酮的1,4-共轭加成反应,取得了突破性进展,获得最高达98%e.e.值的加成产物。     

Notizen zur Synthese sulfonierter Derivate von 5,6,7,8-Tetrahydro-1-naphthylamin und 5,6,7,8-Tetrahydro-2-naphthylamin

Notes on the Synthesis of Sulfonated Derivatives of 5,6,7,8-Tetrahydro-1-naphthylamine and 5,6,7,8-Tetrahydro-2-naphthylamine Sulfonation of 5,6,7,8-tetrahydro-1-naphthylamine ( 1 ) with sulfuric acid gave a mixture of 1-amino-5,6,7,8-tetrahydronaphthalene-2-sulfonic acid ( 2 ), 4-amino-5,6,7,8-tetrahydronaphthalene-2-sulfonic acid ( 13 ) and 4-amino-5,6,7,8-tetrahydronaphthalene-1-sulfonic acid ( 3 ). The same reaction with 5,6,7,8-tetrahydro-2-naphthylamine ( 20 ) yielded 3-amino-5,6,7,8-tetrahydronaphthalene-2-sulfonic acid ( 21 ); formation of 2-amino-5,6,7,8-tetrahydronaphthalene-1-sulfonic acid ( 16 ) or of 3-amino-5,6,7,8-tetrahydronaphthalene-1-sulfonic acid ( 24 ) was not observed. Treatment of 4-bromo-5,6,7,8-tetrahydro-1-naphthylamine ( 4 ) or of its 4-chloro analogue 5 with amidosulfuric acid gave 1-amino-4-bromo-5,6,7,8-tetrahydronaphthalene-2-sulfonic acid ( 9 ) and its 4-chloro analogue 10 , respectively, which were dehalogenated to 2 . Preparations of 13 and 24 were achieved by sulfonation of 5-nitro-1,2,3,4-tetrahydronaphthalene ( 14 ) and 6-nitro-1,2,3,4-tetrahydronaphthalene ( 22 ) to 4-nitro-5,6,7,8-tetrahydronaphthalene-2-sulfonic acid ( 15 ) and 3-nitro-5,6,7,8-tetrahydronaphthalene-1-sulfonic acid ( 23 ), respectively, followed by Béchamp reductions. The sulfonic acid 13 was also obtained by hydrogenolysis of 4-amino-1-bromo-5,6,7,8-tetrahydronaphthalene-2-sulfonic acid ( 11 ) or of its 1-chloro analogue 12 ; compounds 11 and 12 were synthesized from N-(4-bromo-5,6,7,8-tetrahydro-1-naphthyl)acetamide ( 7 ) and from its 4-chloro analogue 8 , respectively, by sulfonation with oleum and subsequent hydrolysis. By ‘baking’ the hydrogensulfate salt of 1 or 20 compounds 3 and 21 were obtained, respectively. Synthesis of 16 was achieved by sulfur dioxide treatment of the diazonium chloride derived from 2-nitro-5,6,7,8-tetrahydro-1-naphthylamine ( 17 ) giving 2-nitro-5,6,7,8-tetrahydronaphthalene-1-sulfonyl chloride ( 18 ), followed by hydrolysis of 18 to the corresponding sulfonic acid 19 and final reduction.     

卤代苯和卤代萘用三氧化硫进行的磺化反应

本文研究 了在非极性溶剂二氯甲烷中卤代苯和卤代萘用SO~3进行的磺化反应. 卤代苯最初开始磺化反应的产物是4-磺酸, 2-卤代萘的产物是8-磺酸. 当用过量的SO~3长时间反应时, 磺化反应得到三取代产物.     

The enantioselective metabolism of p-cymene in rabbits.

p-Cymene (1) was metabolized in rabbits and the following four optically active metabolites, 2-(p-tolyl)-1-propanol (3': R/S = 65:35), 2-(p-tolyl)propanoic acid (5': R/S = 0:100), p-(2-hydroxy-1-methylethyl)benzoic acid (6': R/S = 91:9) and p-(1-carboxyethyl)benzoic acid (8': R/S = 30:70), were isolated in addition to three optically inactive metabolites, 2-(p-tolyl)-2-propanol (2), p-isopropylbenzoic acid (4'), and p-(1-hydroxy-1-methylethyl)benzoic acid (7'). The presumed metabolic pathways of p-cymene in rabbits were confirmed by the administration of the intermediate metabolites (2, 3', 4', and 5'). The enantiomeric ratios of the metabolites, 3' and 6', suggested that omega-hydroxylations of the isopropyl group in 1 and 4' occurred preferentially at the pro-S methyl group. In the metabolism of 1, the S-isomers are predominant in the propanoic acid derivatives, but the R-isomers are rich in the propanol derivatives. It is of interest that the metabolism of 4', however, produced predominantly the corresponding propanol derivative (6'; R/S = 91:9) and propanoic acid derivative (8'; R/S = 80:20) possessing the same R-configuration. Some optically active p-cymene derivatives were also synthesized as standard compounds.     

Vectorial property dependence in bis {4'-(n-pyridyl)-2,2':6',2"-terpyridine}iron(II) and ruthenium(II) complexes with n = 2, 3 and 4

A comparative structural and spectroscopic investigation of the complexes [M(1)2]2+, [M(2)2]2+ and [M(3)2]2+ in which M = Fe or Ru, and ligands 1, 2 and 3 are 4'-(2-pyridyl)-, 4'-(3-pyridyl)- and 4'-(4-pyridyl)-2,2':6',2"-terpyridine, respectively, is reported. The complexes [Ru(1)2]2+, [Ru(2)2]2+ and [Ru(3)2]2+ undergo mono- and bis-N-methylation. The consequences of methylation on the absorption spectra and electrochemical properties are discussed; the solid-state structure of the bis(N-methylated) derivative of [Ru(2)2][PF6]2 is presented.